Kawashima Y, Ogawa T, Kato M, Nakazato A, Tsuchida K, Hatayama K, Hirono S, Moriguchi I
Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Chem Pharm Bull (Tokyo). 1993 Jun;41(6):1060-5. doi: 10.1248/cpb.41.1060.
1,4-Dihydropyridine derivatives having two nitrooxyalkyl moieties as esters at the 3 and 5 positions possess antihypertensive activity. To understand how substituents affect the biological activity, the quantitative structure-activity relationship (QSAR) of 27 compounds was analyzed using the Fuzzy adaptive least-squares (FALS 91) method. The QSAR models suggested that the hydrophobicity and electronic effect at the 4 position of the 1,4-dihydropyridine along with the special structures of the nitrooxyalkylester components are important for antihypertensive activity.
在3和5位具有两个作为酯的硝氧烷基部分的1,4 - 二氢吡啶衍生物具有抗高血压活性。为了了解取代基如何影响生物活性,使用模糊自适应最小二乘法(FALS 91)分析了27种化合物的定量构效关系(QSAR)。QSAR模型表明,1,4 - 二氢吡啶4位的疏水性和电子效应以及硝氧烷基酯成分的特殊结构对抗高血压活性很重要。